The Procter & Gamble Company (NYSE:PG ) Q3 2025 Earnings Conference Call April 24, 2025 8:30 AM ET Company Participants Andre Schulten - Chief Financial Officer Jon Moeller - Chairman, President, Chief Executive Officer Conference Call Participants Lauren Lieberman - Barclays Bryan Spillane - Bank of America Stephen Powers - Deutsche Bank Dara Mohsenian - Morgan Stanley Filippo Falorni - Citigroup Inc. Christopher Carey - Wells Fargo Securities Peter Grom - UBS Bonnie Herzog - Goldman Sachs Mark Astrachan - Stifel Andrea Teixeira - JPMorgan Olivia Tong - Raymond James Robert Ottenstein - Evercore ISI Kevin Grundy - BNP Paribas Kaumil Gajrawala - Jefferies Robert Moskow - TD Cowen Korinne Wolfmeyer - Piper Sandler Operator Good morning, and welcome to Procter & Gamble's Quarter End Conference Call. Today's event is being recorded for replay.
Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Procter & Gamble (PG) came out with quarterly earnings of $1.54 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.52 per share a year ago.
Shares of Procter & Gamble (PG) dipped in premarket trading Thursday after the consumer goods giant's fiscal third-quarter sales came in below analysts' estimates and it cut its full-year outlook.
Procter & Gamble's quarterly earnings topped estimates, but its revenue fell short of expectations. The company also cut its forecast for its full-year core earnings per share and revenue.
Procter & Gamble (PG 2.55%) sells household essentials that people need even in times of economic hardship.
Beyond analysts' top -and-bottom-line estimates for P&G (PG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PG's Q3 results are expected to reflect strong organic sales growth, driven by steady demand for daily-use products and its focus on a strong brand portfolio.
Procter & Gamble, Merck, Medtronic, Johnson & Johnson, Intuit, and Comcast have lagged behind the market's rebound, but they look set to rise from here.
PG's global reach and brand strength support long-term growth, but valuation, China headwinds and macro risks warrant a cautious, hold-worthy outlook.